Presented Research

Presented at ISAM Congress 2019:

Presented at ATS 2019:

• This study has shown there is a relatively linear association of airway pressures with increase in gas flow when using the device over the gas flows investigated.
• The VersaPAP* device could be considered to provide short-term positive pressure support to a patient if there was no direct access to the use of non-invasive mechanical ventilation.

Download poster

Presented at ATS 2019:

Presented at ATS 2019:

• The experiments reported in this study should caution practitioners regarding the interchangeability of OPEP and aerosol delivery devices.
• The findings reinforce that data obtained with one combination of devices cannot be extrapolated to other devices, as performance variation can occur.

Download poster

Presented at ATS 2019:

• The MC 300* nebulizer offers the clinician additional choice when short treatment times and maximizing respirable dose are a priority.

Download poster

Presented at ATS 2019:

• Based on these laboratory data, the VHC with tracheostomy adaptor appears to provide a reliable means of delivering SMI aerosols to patients with a tracheostomy tube or tracheal stoma.
• Further research is required to determine the clinical relevance of these in vitro findings.

Download poster

This laboratory-based study mimicking adult inhalation of suspension- and solution-formulated pMDI-delivered medications highlighted the potential for even a short delay, following inhaler actuation without a VHC, to reduce markedly the efficiency of aerosol delivery to the carinal region of the airway, potentially available for lung delivery.

Download the poster here

The widely differing inspiratory flow profiles in response to training is indicative that use of this particular DPI may not be easy to master for all users after video instruction.

Download the Poster

Presented at the British Thoracic Society December 2018.

Having a child with asthma can be stressful for parents, especially for financially strapped ones struggling to pay for an arsenal of puffers and pills for their child’s treatment. Because of this, those healthcare professionals who recommend spacer chambers may suggest one of many lower-cost versions that are available on the market today. But focusing only on cost may be putting a child’s health at risk.

Presented at the British Thoracic Society December 2018.

This study highlights that not all chambers perform the same and may deliver different amounts of medication.

Clinicians should be aware that the volume of a VHC has a marked effect on the delivery of medication.

See the poster →